Europe is not entering a broad-based recovery. It is entering a capital-intensive structural transformation where growth is concentrated in precisely seven industries. The EU’s top 800 R&D companies deployed €245.5 billion in 2024 — but two sectors, energy (+19.8%) and health (+13%), accounted for virtually all the growth. Knowing where the capital is going — and why — is the essential starting point for EU portfolio construction in 2026.
Sources: JRC EU Industrial R&D Scoreboard Dec 2025 | EDA 2025 | McKinsey MGI Oct 2025 | Mordor Intelligence Jan 2026 | ECB Economic Bulletin 2025 | Novo Nordisk AR 2024 | ASML Q3-2025
The Structural Pivot: Where EU Capital Is Concentrating
Total EU corporate R&D investment reached €233.8 billion in 2024, growing at just 2.9% — down sharply from 9.3% in 2023. The aggregate deceleration masks a dramatic reallocation: energy R&D surged 19.8%, health rose 13%, while automotive stagnated at 0.8% and ICT contracted 8.9% (JRC, December 2025). Europe’s R&D investment is not declining. It is concentrating — into sectors where policy mandates, geopolitical urgency and demographic inevitability create demand floors that transcend economic cycles.
“Europe has a window of opportunity to create regional growth by investing in and scaling deep-tech companies — competing head-to-head with China and the US in sectors that generate both security and prosperity.”
— McKinsey Global Institute, Europe’s Deep-Tech Engine, October 2025
🔬 EU R&D total 2024: €245.5bn; energy +19.8%, health +13%, ICT -8.9% (JRC EU Industrial R&D Scoreboard, December 2025)
🛡 EU defence investment: Record €106bn in 2024 (+42% YoY); projected €130bn in 2025 (European Defence Agency, March 2026)
💻 EU semiconductor market: $68.7bn (2026) → $90.7bn (2031), CAGR 5.71% (Mordor Intelligence, January 2026)
💉 EU deep-tech unicorns: 8% of global total in 2025, up from 4% in 2021 (McKinsey Global Institute, October 2025)
The 7 Industries: Evidence and Investment Logic
01. Renewable Energy [POLICY-DRIVEN]
Energy is the EU’s fastest-growing R&D sector: +19.8% in 2024, outpacing the US (+6%), Trung Quốc (+3.8%) and Japan (-14.2%) simultaneously. Renewable electricity covered 42.5% of EU power in Q1 2025. The Fit for 55 framework mandates an additional €477 billion per year in clean investment — a structural capex floor that transcends market cycles. Vestas and Siemens Energy anchor the investable universe; North Sea offshore wind and Iberian solar are the primary infrastructure vectors.
▸ R&D +19.8% (2024). Fit for 55 capex: €477bn/yr. Renewables: 42.5% EU power Q1 2025. Source: JRC 2025; Rabobank/SUERF; Ember.
02. Defence and Advanced Military Technology [ACCELERATING]
EU defence investment hit a record €106 billion in 2024 — up 42% year-on-year, the steepest single-year rise since the Cold War. The June 2025 NATO summit set a 3.5% of GDP target by 2035; Germany alone committed a cumulative €500 billion over five years. ECB simulations estimate a 1.5% of GDP defence increase raises EU GDP by 0.5% above baseline by 2028. Rheinmetall revenue grew 36% in 2024. Unlike most sectors, defence procurement runs 10–20 year production cycles.
▸ EU spend: €106bn (+42%), 2024. NATO 3.5% GDP target by 2035. Rheinmetall +36%. Source: EDA; ECB Bulletin Issue 5/2025.
03. Semiconductors and Chip Sovereignty [POLICY-DRIVEN]
The EU Chips Act mobilised €43 billion in combined public and private funding targeting 20% of global chip manufacturing by 2030, up from 9% in 2023. The ESMC joint venture broke ground in Dresden in August 2024, targeting 40,000 wafers monthly from 2027. ASML’s EUV tools generated €7.5 billion in Q3-2025 revenue alone. Infineon expects AI-related power-management revenue of €1.5 billion in fiscal 2026. The semiconductor market grows from $68.7 billion in 2026 to $90.7 billion by 2031.
▸ EU Chips Act: €43bn. ASML EUV Q3-2025: €7.5bn. Market CAGR: 5.71% to 2031. Source: Mordor Intelligence; JRC; ASML.
04. Pharmaceuticals and Biotechnology [ACCELERATING]
EU health companies grew R&D 13% in 2024 — outperforming the US (+7.1%), Japan (+9.1%) and China (+0.1%). Healthcare spending across EU member states will exceed 10% of GDP by 2025 (OECD). Novo Nordisk’s GLP-1 franchise generated DKK 232.3 billion in 2024 revenue (+25%), briefly making it Europe’s most valuable listed company. Demographic ageing — old-age dependency rising from 33.9% to 56.7% by 2050 — creates structural demand that is recession-resistant by definition.
▸ EU health R&D +13% (2024). Healthcare: >10% EU GDP. Novo Nordisk 2024: DKK 232.3bn (+25%). Source: JRC 2025; OECD; Novo Nordisk AR.
05. Artificial Intelligence and Data Infrastructure [ACCELERATING]
EU data centre capacity is projected to triple by 2027, with AI compute clusters concentrating in Germany and the Netherlands. Closing just one-quarter of the EU-US productivity gap would generate €500 billion per year in additional euro area output (ECB, February 2026). The critical challenge: EU ICT R&D contracted 8.9% in 2024 — the sharpest decline of any sector — while US tech firms deployed €2 trillion more in digital technologies than EU peers over five years. SAP’s enterprise AI and Nokia’s network intelligence are the most visible EU-native positions.
▸ Data centres x3 by 2027. Productivity gap value: €500bn/yr (ECB). ICT R&D: -8.9% (2024). Source: FT 2025; ECB Feb 2026; JRC; McKinsey MGI.
06. Space Technology and Deep Tech [POLICY-DRIVEN]
European deep-tech unicorns now represent 8% of global total — doubled from 4% in 2021 (McKinsey MGI). Full realisation of Europe’s deep-tech ecosystem could generate $1 trillion in economic growth by 2030. Mistral AI raised a $2 billion Series C in 2025. Airbus and Thales anchor institutional space capacity. Space technology uniquely intersects three simultaneous EU policy priorities: defence, climate monitoring and sovereign communications infrastructure.
▸ EU deep-tech unicorn share: 8% globally. Potential: $1tn by 2030. Source: McKinsey MGI, October 2025.
07. Green Hydrogen and Industrial Decarbonisation [POLICY-DRIVEN]
Green hydrogen is the long-cycle, policy-anchored bet in Europe’s energy transition. The EU Hydrogen Strategy targets 10 million tonnes of domestic production by 2030. EU companies lead globally in green patents for energy-intensive industry applications (JRC, 2025). Siemens Energy and Air Liquide are the primary industrial-scale positions; ThyssenKrupp’s hydrogen-based direct-reduced iron steelmaking is the most advanced hard-to-abate sector pilot. The EU ETS carbon price functions as a structural cost driver accelerating adoption regardless of market conditions.
▸ EU hydrogen target: 10Mt by 2030. EU leads globally in energy-intensive green patents. Source: EU Commission; JRC 2025.
Sector Scorecard
| Industry | Key EU Metric | Benchmark | Risk |
| Renewable Energy | R&D +19.8% in 2024 (JRC) | Vestas, Siemens Energy | Energy price volatility |
| Defence Tech | €106bn spend +42% (EDA 2024) | Rheinmetall, Thales | Budget consolidation |
| Semiconductors | Market $68.7bn; CAGR 5.71% to 2031 | ASML, Infineon | China export controls |
| Pharma & Biotech | R&D +13% (2024), outpacing US (JRC) | Novo Nordisk, Roche | Drug pricing regulation |
| AI & Data Infrastructure | Data centres x3 by 2027 (FT) | SAP, Nokia | US platform dominance |
| Space & Deep Tech | 8% of global unicorns (MGI 2025) | Airbus, Mistral AI | Funding gap vs US/China |
| Green Hydrogen | EU target: 10Mt by 2030 | Siemens Energy, Air Liquide | Cost parity timeline |
Sources: JRC 2025; EDA 2025; Mordor Intelligence; McKinsey MGI; ECB; EU Commission. Not investment advice.
Four Risks That Could Disrupt the Cycle
- Energy cost asymmetry: EU industrial energy costs structurally exceed US levels, reducing manufacturing competitiveness even as green investment rises — simultaneously driving renewable capex and suppressing the industrial base it is meant to serve.
- AI execution gap: EU ICT R&D fell 8.9% in 2024 while US tech firms out-invested EU peers by €2 trillion over five years. Regulatory leadership has not yet produced commercial AI leadership.
- Defence fiscal sustainability: High-debt member states — Italy and France — face constraints sustaining 3.5% of GDP NATO targets without crowding out other public investment priorities.
- China manufacturing scale: EU companies lead in green patents, but China out-invests EU manufacturing at 3:1 in gross fixed capital formation. EU advantage must be in proprietary technology, not volume production.
Conclusion: Policy-Anchored, Not Cycle-Dependent
Europe’s next growth cycle will be concentrated, not broad-based — in industries where policy mandates create structural demand floors, geopolitical pressure forces sovereign investment, and demographic reality generates irreversible consumption shifts. In a macro environment where EU GDP growth is projected at 1.2–1.4% through 2027, the seven industries profiled here are growing at multiples of that rate. The common thread is that their growth is policy-anchored rather than cycle-dependent — a distinction that matters fundamentally for long-duration portfolio construction in a lower-growth European economy.
